Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel–ethinylestradiol combination

References

• Goldzieher J W. Polycystic ovarian disease. Fertil Steril 1981; 35: 371
   PubMed Web of Science ®Google Scholar
• Yen S SC. The polycystic ovary syndrome. Clin Endocrinol (Oxf) 1980; 12: 177
   PubMed Web of Science ®Google Scholar
• Jackson R L., Dockerty M B. The Stein-Leventhal syndrome. Analysis of 43 cases with special reference to association with endometrial carcinoma. Am J Obstet Gynecol 1975; 73: 161
   Google Scholar
• Andersson R N., Givens J R., Weiser W L., Umstot E S. Response of the binding capacity of plasma testosterone—estradiol-binding globulin to norethindrone and mestranol 0.1 mg in polycystic ovarian disease. Am J Obstet Gynecol 1976; 125: 166
   Google Scholar
• Shailaja G R., Madhwa H GR, Talbert L M., Sloan C, Hicks B. Normalization of testosterone levels using a low estrogen containing oral contraceptive in women with polycystic ovary syndrome. Obstet Gynecol 1982; 60(l)15
   Google Scholar
• Maroulis G B. Evaluation of hirsutism and hyperandro-genemia. Fertil Steril 1981; 36: 273
   PubMed Web of Science ®Google Scholar
• Stadel B V. Oral contraceptives and cardiovascular disease. New Engl J Med 1981; 305: 672
   PubMed Web of Science ®Google Scholar
• Miller N E., Förde O H., Thelle D S., Mjös O D. The Tromsö Heart-Study. High density lipoprotein and coronary heart-disease: A prospective case-control study. Lancet 1977; i: 965
   Web of Science ®Google Scholar
• Gordon T, Castell W P., Hjortland M C., Kannel W B., Dawber T R. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Am J Med 1977; 62: 707
   PubMed Web of Science ®Google Scholar
• Mattsson L-Å, Cullberg G, Hamberger L, Samsioe G, Silfverstolpe G. Lipid metabolism in women with polycystic ovary syndrome: Possible implications for an increased risk of coronary heart disease. Fertil Steril 1984; 42: 579
   PubMed Web of Science ®Google Scholar
• Wortsman J, Soler N G. Abnormalities of fuel metabolism in the polycystic ovary syndrome. Obstet Gynecol 1982; 60: 342
   PubMed Web of Science ®Google Scholar
• Cullberg G, Hamberger L, Mattsson L-Å, Mobacken H, Samsioe G. Effects of a low-dose desogestrel—ethi-nyl-estradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a poly-cystic ovary syndrome. Acta Obstet Gynecol Scand 1985; 64: 195
   PubMed Web of Science ®Google Scholar
• Metropolitan Life Insurance Company: Frequency of overweight and underweight. Stat Bull Metrop Life In-sur Co 1960; 41: 4
   Google Scholar
• Walton K W., Scott P J., Dykes P N., Davies J WL. The significance of alterations in serum lipids in thyroid dysfunction. II. Alterations of the metabolism and turnover of 131I-low-density lipoproteins in hypo-thyroidism and thyrotoxicosis. Clin Sci 1965; 29: 217
   PubMed Web of Science ®Google Scholar
• Knopp R H., Walden C E., Wahl P W., Hoover J J., War-mich G R., Albers J J., Ogilvie J T., Hazzard W R. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population. Relationship to estrogen and pro-gestin potency. J Clin Endocrinol Metab 1981; 53: 1123
   PubMed Web of Science ®Google Scholar
• Crona N. Hormonal treatment and lipoprotein metabolism. Effects of exogenous sex steroids used for contraception, hormonal replacement and adjuvant cancer therapy. Diss University of Gothenburg, GothenburgSweden 1983
   Google Scholar
• Larsson-Cohn U, Fåhreus L, Wallentin L, Zador G. Lipoprotein changes may be minimized by proper composition of a combined oral contraceptive. Fertil Steril 1981; 35: 172
   PubMed Web of Science ®Google Scholar
• Bradley D D., Wingerd J, Petitti D B., Krauss R M., Ram-charan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and proges-tins. New Engl J Med 1978; 299: 17
   PubMed Web of Science ®Google Scholar
• Glueck C J., Taylor H L., Jacobs D, Morrison J A., Beaglehole R, Williams O D. Plasma high-density lipoprotein cholesterol: Association with measurements of body mass. Circulation 1980; 62(Suppl. IV)62
   Google Scholar
• Wahl P W., Warnick G R., Albers J J., Hoover J J., Walden C E., Bergelin R O., Ogilvie J T., Hazzard W R., Knopp R H. Distribution of lipoprotein triglyceride and lipoprotein cholesterol in an adult population by age, sex and hormone use. Atherosclerosis 1981; 39: 111
   Google Scholar
• Wallentin L, Larsson-Cohn U. Metabolic and hormonal effects of postmenopausal oestrogen replacement. II. Plasma lipids. Acta Endocrinol (Copenh) 1977; 86: 597
   PubMedGoogle Scholar
• Samsioe G. Study on effect of 30 μg ethinylestradiol (EE) +150 μg desogestrel on lipid and lipoprotein metabolism in healthy volunteers, also in comparison with 30 μg EE+150 μg levonorgestrel. Acta Obstet Gynecol Scand Suppl 1982; 111: 55
   Google Scholar